A share price of Repligen Corp. [RGEN] is currently trading at $146.70, up 1.53%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RGEN shares have gain 3.46% over the last week, with a monthly amount drifted -11.18%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Repligen Corp. [NASDAQ: RGEN] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Overweight rating and assigned the stock a price target of $180. Previously, Deutsche Bank upgraded its rating to Buy on June 26, 2024, and dropped its price target to $155. On June 18, 2024, Guggenheim initiated with a Neutral rating. The Benchmark Company downgraded its rating to a Hold. Wells Fargo initiated its recommendation with a Overweight and recommended $185 as its price target on July 20, 2023. In a note dated March 28, 2023, The Benchmark Company initiated an Buy rating and provided a target price of $230 on this stock.
Repligen Corp. experienced fluctuations in its stock price throughout the past year between $110.45 and $211.13. Currently, Wall Street analysts expect the stock to reach $189.5 within the next 12 months. Repligen Corp. [NASDAQ: RGEN] shares were valued at $146.70 at the most recent close of the market. An investor can expect a potential return of 29.18% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
Trailing Twelve Months sales for Repligen Corp. [NASDAQ:RGEN] were 602.35M which represents -3.20% decline. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 144.13 points at the first support level, and at 141.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 148.14, and for the 2nd resistance point, it is at 149.59.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Repligen Corp. [NASDAQ:RGEN] is 6.65. In addition, the Quick Ratio stands at 5.56 and the Cash Ratio stands at 4.64. Considering the valuation of this stock, the price to sales ratio is 13.64, the price to book ratio is 4.13.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Officer, that happened on Sep 10 ’24 when 22191.0 shares were purchased. Senior VP, R&D, KURIYEL RALF completed a deal on Aug 02 ’24 to sell 7148.0 shares. Meanwhile, Senior Vice President Ralf Kuriyel bought 7148.0 shares on Aug 02 ’24.
